Oakbrook Investments’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-22,100
Closed -$4.7M 614
2014
Q4
$4.7M Sell
22,100
-25,225
-53% -$5.02M 0.25% 85
2014
Q3
$8.43M Sell
47,325
-44,650
-49% -$7.42M 0.45% 53
2014
Q2
$15.6M Sell
91,975
-144,400
-61% -$22.5M 0.47% 56
2014
Q1
$29.3M Sell
236,375
-15,800
-6% -$1.92M 0.93% 28
2013
Q4
$28M Buy
252,175
+136,575
+118% +$13M 0.78% 34
2013
Q3
$10.5M Sell
115,600
-7,850
-6% -$705K 0.31% 84
2013
Q2
$10.4M Buy
+123,450
New +$12.8M 0.3% 84

Other funds holding AGN

Oakbrook Investments's AGN Position: Q1 2015 in Review

Oakbrook Investments sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 22,100 shares — an estimated $4.7M sold.

Oakbrook Investments first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $29.3M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Oakbrook Investments reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Oakbrook Investments sold 22,100 Allergan Inc shares in Q1 2015, an estimated $4.7M.
  • Oakbrook Investments first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Oakbrook Investments's Allergan Inc position peaked at $29.3M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Oakbrook Investments's 13F filing for Q1 2015, filed 16 Apr 2015.